13.07.2015 Views

Scientific Session 1 — Breast Imaging: Mammography

Scientific Session 1 — Breast Imaging: Mammography

Scientific Session 1 — Breast Imaging: Mammography

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Wednesday<strong>Scientific</strong> <strong>Session</strong> 17—Gastrointestinal <strong>Imaging</strong>: Pancreaticobiliary <strong>Imaging</strong>abnormalities with nearly one half of these major findings potentiallyimpacting or resulting in new therapeutic interventions. New interventionswere more likely in the major finding group with most showingconcordance. These results help bolster the argument in favor of the ondemandradiograph by providing evidence of its clinical utility in patientmanagement decisions.144. Lung Changes After Esophagectomy: Longitudinal Analysis on CTWoo, J.*; Harris, R.; Kalra, M.; Lanuti, M.; Shepard, J.; Digumarthy, S.Massachusetts General Hospital, Boston, MAAddress correspondence to J. Woo (james.kh.woo@gmail.com)Objective: To assess the lung findings on CT scans in patients afteresophagectomy and to assess their clinical significance.Materials and Methods: The radiology database and electronic medicalrecord were searched to identify patients who underwent esophagectomyand who had baseline and follow-up CT studies. Patients with prolongedpostoperative complications, recurrent/metastatic disease in thethorax, and follow-up of less than 6 months were excluded. The scanswere assessed by two thoracic radiologists for bronchial wall thickening,bronchiectasis, tree-in-bud sign or ground-glass opacities (GGO),consolidation, septal thickening or reticulation, honeycombing, mosaicattenuation, and volume loss. Changes attributable to radiation therapy,if any, were excluded. Clinical and laboratory assessment of respiratorystatus during the follow-up period was recorded. The results wereanalyzed using the paired Student t test.Results: Out of a total of 164 patients, 51 met the inclusion criteria(male:female 44:7, mean age ± SD, 65 ± 10 years; age range, 41–81years). There were 286 follow-up CT scans over 98.3 months (mean ±SD, 36.3 ± 21.8 months; range, 7.4–98.3 months). The mean number ofCT scans ± SD for each patient was 6.6 ± 3 (range, 2–15). Esophagectomywas performed for cancer in 47 of 51 patients (92%) and for benigncauses in four of 51 patients (8%). Anatomic continuity was establishedby gastric pull-through in 50 of 51 patients (98%) and colonic interpositionin one of 51 patients (2%). Neoadjuvant and adjuvant chemo- orradiotherapy was given in 34 of 51 (67%). There was new tree-in-budsign or GGO in 38 of 51 (75%), bronchial wall thickening in 22 of 51(43%), consolidation in 15 of 51 (29%), bronchiectasis in 12 of 51(24%), septal thickening or reticulation in seven of 51 (14%), volumeloss in four of 51 (8%), and mosaic attenuation in one of 51 patients(2%). No honeycombing was identified. Forty-two of 51 patients (82%)had at least one new finding during follow-up. Findings were bilateral in30 of 42 (71%), right only in seven of 42 (17%), left only in five of 42(12%), and dependent in 35 of 42 (83%). Clinical assessment of respiratorystatus was categorized as “normal” in 39 of 51 (76%), and “episodes ofaspiration” in 10 of 51 (20%). Only two of 51 patients (4%) had abnormalpulmonary function tests.Conclusion: Reversible and nonreversible changes related to aspirationafter esophagectomy and reanastomosis were frequently noted but therewas no significant decline in respiratory status over time.<strong>Scientific</strong> <strong>Session</strong> 17 —Gastrointestinal <strong>Imaging</strong>:Pancreaticobiliary <strong>Imaging</strong>Wednesday, May 4, 2011Abstracts 145-153145. Bile Duct Response to Secretin Stimulation During Secretin-Enhanced MRCP: Assessment in Subjects With Pancreas Divisumand Its Meaning in MRI Evaluation of Pancreatobiliary RefluxRestaino, G.*; Occhionero, M.; Missere, M.; Barrassi, M.; Bufi, E.;Mutignani, M.; Sallustio, G. Catholic University, Campobasso, ItalyAddress correspondence to G. Restaino (gennares@hotmail.com)Objective: Pancreatobiliary reflux (PBR) is an important risk factor forbiliary malignancies. Secretin-enhanced MRCP (S-MRCP) may directlyvisualize PBR, by demonstrating common bile duct (CBD) enlargementfollowing secretin stimulation; however, in this evaluation it is crucialto consider the fraction of CBD enlargement as a result of physiologicbiliary secretory response to secretin administration. In pancreas divisumthe largest part of the pancreas drains into the papilla minor throughthe dorsal pancreatic duct separately from the CBD. The purpose of thisstudy was to assess the normal enlargement of CBD after secretin stimulationdue to biliary secretory response in patients in whom the pancreaticanatomy (pancreas divisum) prevents substantial PBR.Materials and Methods: We retrospectively evaluated the 55 S-MRCPswith diagnosis of pancreas divisum performed at our institution betweenJanuary 2004 and August 2009. On 2D MRCP images the maximum diameterof CBD was measured before and after secretin administration.Results: The mean baseline diameter of CBD was 5.2 ± 2.8 mm. In sevenof 55 patients (13%), there was no change after secretin administration;in six of 55 (11%), there was a slight decrease (–0.2 ± 0.2 mm), while in42 of 55 (76%) an increase was observed (0.8 ± 0.7 mm).Conclusion: After administration of secretin, increase of diameter ofCBD due to physiologic biliary secretory response is common. Since themean increase of CBD diameter was 0.8 ± 0.7 mm, it is advisable that inS-MRCP any increase in CBD diameter greater than 2.2 mm after secretinadministration should raise suspicion of overt or occult pancreatobiliaryreflux.146. CT of the Common Hepatic Duct: Frequency of Visualizationin Unenhanced and Contrast-Enhanced StudiesMcArthur, T.*; Lockhart, M.; Planz, V.; Fineberg, N.; Berland, L. TheUniversity of Alabama at Birmingham, Birmingham, ALAddress correspondence to T. McArthur (tatummc@yahoo.com)Objective: The purpose of this study was to evaluate normal extrahepaticbile ducts to determine the frequency of CT visualization of the commonhepatic duct (CHD) at the porta hepatis.*Will present paperA55

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!